Here are five things to know.
1. The CNRDI’s main goal is to improve the lifespan and quality of life of rare disease patients, according to an emailed release.
2. The institute will track patient outcomes and treatment regimens, creating a database to advance rare disease research and knowledge gathering.
3. The CNRDI will also test and develop new therapies for rare diseases and provide training specific to rare diseases for clinicians, genetic counselors, nurses, researchers and allied health professionals, according to the report.
4. The National Organization for Rare Disorders designated CNRDI as its first Center of Excellence for Clinical Care for Rare Diseases.
5. Marshall Summar, MD, chief of genetics and metabolism at Children’s National Health System, will head the institute. Dr. Summar also serves as NORD’s board chairman.
More articles on hospital and physician issues:
ERs taking steps to prescribe fewer opioids
Harvard Medical School dean launches diversity task force
Woman posing as physician administered physicals at Philadelphia high school
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
